Sandy works with research sites, sponsors, and patient advocacy groups in support of WCG’s mission to accelerate the development of new medical therapies by improving the conduct and quality of clinical trials. She provides consultation to research sites by strategically aligning clinical solutions to improve and create efficient processes in the areas of ethical review, biosafety, trial initiation, research financial services, resource augmentation, and support for investigator-initiated trials with DSMBs and statistical consulting. Prior to joining WCG, Sandy led a large oncology site management organization of independent practices and hospital research programs. She currently is a Board member of SASI, a non-profit research site accreditation organization.
